ACUITY-CHS, LLC: $15.0M Department of Homeland Security Contract

The Department of Homeland Security, U.S. Customs and Border Protection, has awarded a $15.0M delivery order to ACUITY-CHS, LLC for pre-employment medical services testing. This contract, spanning from April 24, 2026, to April 23, 2027, ensures that new hires meet the necessary health standards for their roles. While the contract value is substantial, ACUITY-CHS, LLC is a privately held company, meaning there is no direct stock market impact from this specific award.

Since ACUITY-CHS, LLC is not publicly traded, there is no direct parent company or revenue impact to calculate for a publicly listed entity. However, this contract highlights ongoing federal demand for occupational health services. Publicly traded companies operating in the broader healthcare services and medical testing sectors could see this as a positive signal for continued government spending in these areas. Examples of such companies include Quest Diagnostics ($DGX) and LabCorp ($LH), which provide similar medical testing services, though they are not directly involved in this specific award.

There is no direct legislative connection among the provided bill signals that specifically authorizes or appropriates funding for "pre-employment medical services testing" for U.S. Customs and Border Protection. The closest related bill, HR8447, "To protect against seasonal and pandemic influenza, and for other purposes," is too general to be directly linked to pre-employment medical screenings. The contract appears to be part of routine operational expenditures for U.S. Customs and Border Protection. The recent Executive Order on "Accelerating Medical Treatments for Serious Mental Illness" is not directly relevant to pre-employment physical health screenings.

Potential supply chain beneficiaries for medical services contracts often include medical equipment suppliers and pharmaceutical companies. For instance, companies like Thermo Fisher Scientific ($TMO) or Danaher Corporation ($DHR) could supply diagnostic equipment and reagents used in such testing. Additionally, smaller, specialized medical staffing or clinic management companies could act as subcontractors. The historical pattern for such essential government services contracts is one of consistent renewal and stable demand, providing predictable revenue for the contractors involved.

This contract is a routine operational expenditure, and while it provides significant revenue to the private recipient, it does not represent a transformative event for the broader Healthcare sector or any specific publicly traded company. The impact is primarily localized to the direct contractor.